KRYS
Price
$161.75
Change
-$3.08 (-1.87%)
Updated
Dec 23, 11:07 AM (EDT)
70 days until earnings call
PTN
Price
$0.98
Change
+$0.12 (+13.95%)
Updated
Dec 20, 04:59 PM (EDT)
57 days until earnings call
Ad is loading...

KRYS vs PTN

Header iconKRYS vs PTN Comparison
Open Charts KRYS vs PTNBanner chart's image
Krystal Biotech
Price$161.75
Change-$3.08 (-1.87%)
Volume$100
CapitalizationN/A
Palatin Technologies
Price$0.98
Change+$0.12 (+13.95%)
Volume$679
CapitalizationN/A
KRYS vs PTN Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. PTN commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and PTN is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (KRYS: $164.83 vs. PTN: $0.97)
Brand notoriety: KRYS and PTN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 336% vs. PTN: 777%
Market capitalization -- KRYS: $4.74B vs. PTN: $22.7M
KRYS [@Biotechnology] is valued at $4.74B. PTN’s [@Biotechnology] market capitalization is $22.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whilePTN’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • PTN’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than PTN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while PTN’s TA Score has 5 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 6 bearish.
  • PTN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PTN is a better buy in the short-term than KRYS.

Price Growth

KRYS (@Biotechnology) experienced а +0.73% price change this week, while PTN (@Biotechnology) price change was +10.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

KRYS is expected to report earnings on Mar 03, 2025.

PTN is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.74B) has a higher market cap than PTN($22.7M). KRYS YTD gains are higher at: 32.863 vs. PTN (-75.681). KRYS has higher annual earnings (EBITDA): 181M vs. PTN (-32.01M). KRYS has more cash in the bank: 588M vs. PTN (2.38M). PTN has less debt than KRYS: PTN (470K) vs KRYS (7.48M). KRYS has higher revenues than PTN: KRYS (242M) vs PTN (2.38M).
KRYSPTNKRYS / PTN
Capitalization4.74B22.7M20,872%
EBITDA181M-32.01M-565%
Gain YTD32.863-75.681-43%
P/E Ratio92.56N/A-
Revenue242M2.38M10,151%
Total Cash588M2.38M24,664%
Total Debt7.48M470K1,591%
FUNDAMENTALS RATINGS
KRYS vs PTN: Fundamental Ratings
KRYS
PTN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
14100
SMR RATING
1..100
80100
PRICE GROWTH RATING
1..100
5665
P/E GROWTH RATING
1..100
9995
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTN's Valuation (72) in the Biotechnology industry is in the same range as KRYS (83) in the Pharmaceuticals Major industry. This means that PTN’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (14) in the Pharmaceuticals Major industry is significantly better than the same rating for PTN (100) in the Biotechnology industry. This means that KRYS’s stock grew significantly faster than PTN’s over the last 12 months.

KRYS's SMR Rating (80) in the Pharmaceuticals Major industry is in the same range as PTN (100) in the Biotechnology industry. This means that KRYS’s stock grew similarly to PTN’s over the last 12 months.

KRYS's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as PTN (65) in the Biotechnology industry. This means that KRYS’s stock grew similarly to PTN’s over the last 12 months.

PTN's P/E Growth Rating (95) in the Biotechnology industry is in the same range as KRYS (99) in the Pharmaceuticals Major industry. This means that PTN’s stock grew similarly to KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSPTN
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 7 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPAD3.650.23
+6.73%
Offerpad Solutions
BHLB28.580.78
+2.81%
Berkshire Hills Bancorp
NNVC1.490.04
+2.76%
NanoViricides
WRB58.570.54
+0.93%
WR Berkley Corp
BKH57.97-0.08
-0.14%
Black Hills Corp

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with CLDX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+2.49%
CLDX - KRYS
56%
Loosely correlated
-0.95%
BEAM - KRYS
49%
Loosely correlated
+8.04%
ZLDPF - KRYS
45%
Loosely correlated
+0.71%
BPMC - KRYS
45%
Loosely correlated
+1.36%
RXRX - KRYS
45%
Loosely correlated
-0.99%
More

PTN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTN has been loosely correlated with FATE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTN jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTN
1D Price
Change %
PTN100%
+12.55%
FATE - PTN
41%
Loosely correlated
+1.20%
MDGL - PTN
32%
Poorly correlated
+5.12%
KRYS - PTN
32%
Poorly correlated
+2.49%
AVCTF - PTN
30%
Poorly correlated
-5.29%
DNLI - PTN
30%
Poorly correlated
-0.19%
More